A comparison between 12 versus 20 weeks of trimethoprim-sulfamethoxazole as oral eradication treatment for melioidosis: an open-label, pragmatic, multicenter, non-inferiority, randomized controlled trial

A comparison between 12 versus 20 weeks of trimethoprim-sulfamethoxazole as oral eradication treatment for melioidosis: an open-label, pragmatic, multicenter, non-inferiority, randomized controlled trial

<p><strong>Background</strong> Treatment of melioidosis comprises intravenous drugs for at least 10 days, followed by oral trimethoprim-sulfamethoxazole (TMP-SMX) for 12 to 20 weeks. Oral TMP-SMX is recommended for 12 weeks in Australia and 20 weeks in Thailand.</p> <p>...

Full description

Bibliographic Details
Main Authors: Anunnatsiri, S, Chaowagul, W, Teparrukkul, P, Chetchotisakd, P, Tanwisaid, K, Khemla, S, Narenpitak, S, Pattarapongsin, M, Kongsawasd, W, Pisuttimarn, P, Thipmontree, W, Mootsikapun, P, Chaisuksant, S, Chierakul, W, Day, NPJ, Limmathurotsakul, D
Format: Journal article
Language:English
Published: Oxford University Press 2020

Similar Items

Similar Items